BRAF and metastatic melanoma: The effect of BRAF mutation on metastatic melanoma is controversial [94, 95], though our study found that metastatic patients with BRAF mutations in the TCGA-SKCM cohort had favorable survival (Fig. 2D, P = 0.024).